Skip to main content Accessibility help
×
Home

Pentastarch resuscitation in severe sepsis and septic shock

  • Robert S. Green (a1), Peter J. Zed (a2) and Lauralyn McIntyre (a3)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pentastarch resuscitation in severe sepsis and septic shock
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Pentastarch resuscitation in severe sepsis and septic shock
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Pentastarch resuscitation in severe sepsis and septic shock
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

Department of Medicine (Division of Critical Care Medicine), Department of Emergency Medicine, Rm. 377 Bethune Building, 1278 Tower Rd., Halifax NS B3H 2Y9; greenrs@dal.ca

References

Hide All
1.Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235–40.
2.Alderson, P, Bunn, F, Lefebvre, C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;(4):CD001208.
3.Finfer, S, Bellomo, R, Boyce, N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247–56.
4.McIntyre, LA, Fergusson, D, Cook, DJ, et al. Resuscitating patients with early severe sepsis: a Canadian multicentre observational study. Can J Anaesth 2007;54:790–8.
5.Vincent, JL, Moreno, R, Takala, J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ/dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10.
6.Strehlow, MC, Emond, SD, Shapiro, NI, et al. National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med. 2006;48:326–31.
7.Martin, GS, Mannino, DM, Eaton, S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–54.
8.Angus, DC, Linde-Zwirble, WT, Lidicker, J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–10.
9.Green, RS, Djogovic, D, Gray, S, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443–59.
10.Dellinger, RP, Levy, MM, Carlet, JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296327.
11.Green, RS, Hall, RI. Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion. J Cardiothorac Vasc Anesth 2008;22:485–91.
12.Traylor, RJ, Pearl, RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996;83:209–12.
13.Imm, A, Carlson, RW. Fluid resuscitation in circulatory shock. Crit Care Clin 1993;9:313–33.
14.Ross, AD, Angaran, DM. Colloids vs. crystalloids — a continuing controversy. Drug Intell Clin Pharm 1984;18:202–12.
15.Vincent, JL, Navickis, RJ, Wilkes, MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004;32:20292038.
16.Wilkes, MM, Navickis, RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135:149–64.
17.Haynes, GR, Navickis, RJ, Wilkes, MM. Albumin administration — what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003;20:771–93.
18.Choi, PT, Yip, G, Quinonez, LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200–10.
19.Dieterich, HJ. Recent developments in European colloid solutions. J Trauma 2003;54(Suppl):S26–30.
20.Schortgen, F, Deye, N, Brochard, L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004;30:2222–9.
21.Boldt, J. Volume therapy in cardiac surgery: Are Americans different from Europeans? J Cardiothorac Vasc Anesth 2006;20:98105.
22.Schortgen, F, Lacherade, JC, Bruneel, F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911–6.
23.The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–97.

Related content

Powered by UNSILO

Pentastarch resuscitation in severe sepsis and septic shock

  • Robert S. Green (a1), Peter J. Zed (a2) and Lauralyn McIntyre (a3)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.